ARCHIVES

Phase II ThermoDox Trial Demonstrates Positive Response

This article is from The Cancer Letter archive.

Vol. 37 No. 8 | August 29, 2014

Download PDF Visit The Full Archive

Related Articles

Human Embryo Panel Defines Acceptable Research For Funding

September 30, 1994

Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint

December 31, 2010

ASCO Annual Meeting: New Regimens Promising For Metastatic Colon Cancer

July 28, 2006

New Publications

March 16, 1990

FASEB Says NIH Budge Should Reach $10 Bil. In Fiscal 1993

January 10, 1992

NCI Starts “Exceptional Responders” Study

September 26, 2014